Clinical and research validity of hadrontherapy with ion beams

Critical Reviews in Oncology/Hematology

Volumn 51, Issue 2, 2004, Pages 81-90

  Orecchia, Roberto ^a,b   Krengli, Marco ^c   Jereczek Fossa, Barbara A ^a   Franzetti, Silvia ^a   Gerard, Jean Pierre ^d  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^d CENTRE ANTOINE LACASSAGNE   (France)

Author keywords

Clinical results; Hadrontherapy; Ion therapy; Radiotherapy; Tumours

Indexed keywords

ATOMIC PARTICLE; BRAIN TUMOR; CANCER RADIOTHERAPY; CHOROID MELANOMA; CLINICAL TRIAL; ECONOMIC ASPECT; HADRON; HEAD AND NECK TUMOR; HUMAN; LIVER CELL CARCINOMA; LUNG CARCINOMA; MATHEMATICAL COMPUTING; MIDDLE EAR EFFUSION; MUCOSA INFLAMMATION; NAUSEA; NONHUMAN; OSTEOSARCOMA; OTITIS; PHYSICAL CHEMISTRY; PROSTATE TUMOR; RADIOBIOLOGY; RADIOSENSITIVITY; REVIEW; SINUSITIS; SKIN TOXICITY; SKULL TUMOR; SOCIAL ASPECT; SOFT TISSUE SARCOMA;

ANIMALS; HUMANS; IONS; NEOPLASMS; RADIOTHERAPY;

EID: 3242815373     PISSN: 10408428     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.critrevonc.2004.04.005     Document Type: Review

References (55)

1. Orecchia R., Zurlo A., Loasses A., et al. Particle beam therapy (hadrontherapy): basis for interest and clinical experience. Eur. J. Cancer. 34:1998;459-468
2. Krengli M., Liebsch J.N., Hug E.B., Orecchia R. Review of current protocols for protontherapy in the USA. Tumori. 84:1998;209-216
3. Kraft G. The radiobiological and physical basis for radiotherapy with protons and heavier ions. Strahlenther. Onkol. 166:1990;10-13
4. Slater J.M., Willer D.W., Archambeau J.O. Development of a hospital-based proton beam treatment centre. Int. J. Radiat. Oncol. Biol. Phys. 14:1988;761-775
5. Slater J.M., Archambeau J.O., Willer D.W., Notarus M.I., Preston W., Slater J.D. The proton treatment centre at the Loma Linda University Medical Centre: rationale and description of its development. Int. J. Radiat. Oncol. Biol. Phys. 22:1992;383-389
6. Debus J., Haberer T., Schulz-Ertner D., et al. Carbon ion irradiation of skull base tumours at GSI. First clinical results and future perspectives. Strahlenther. Onkol. 176:2000;211-216
7. Koehler A.M., Schneider R.J., Sisterson J.M. Flattening of proton dose distributions for large field radiotherapy. Med. Phys. 4:1977;297-301
8. Suzuki M., Kase Y., Yamaguchi H., Kaqnai T., Ando K. Change in radiosensitivity with fractionated-dose irradiation of carbon-ion beams in five different human cell lines. Int. J. Radiat. Oncol. Biol. Phys. 48:2000;241-250
9. Durante M., Yamada S., Ando K., et al. X-Rays vs carbon-ion tumour therapy: cytogenetic damage in lymphocytes. Int. J. Radiat. Oncol. Biol. Phys. 47(3):2000;793-798
10. Jakel O., Kramer M., Karger C.P., Debus J. Treatment planning for heavy ion radiotherapy clinical implementation and application. Phys. Med. Biol. 46:2001;1101-1106
11. Kramer M. Treatment planning for heavy-ion radiotherapy: biological optimisation of multiple beam ports. J. Radiat. Res. 42:2001;39-46
12. Baroni G., Ferrigno G., Orecchia R., Pedotti A. Real-time three-dimensional motion analysis for patient positioning verification. Radiother. Oncol. 54:2000;21-27
13. Karger C.P., Jakel O., Heeg P., Hartmann G.H. Clinical dosimetry for heavy ion therapy. Z. Med. Phys. 12:2002;159-169. [in German]
14. Agosteo S. Radiation protection at medical accelerators. Radiat. Prot. Dosimet. 96:2001;393-406
15. Ando K., Koike S., Ohira C., et al. Accelerated reoxygenation of a murine fibrosarcoma after carbon-ion radiation. Int. J. Radiat. Biol. 75:1999;505-512
16. Matsumoto H., Hayashi S., Hatashita M., et al. Induction of radiorestistance to accelerated carbon-ion beams in recipient cells by nitric oxide excreted from irradiated donor cells of human glioblastoma. Int. J. Radiat. Biol. 76:2000;1649-1657
17. Tsuchida Y., Tsuboi K., Ohyama H., Ohno T., Nose T., Ando K. Cell death induced by high-linear-energy transfer carbon beams in human glioblastoma cell lines. Brain Tumor Pathol. 15:1998;71-76
18. Castro J.R. Results of heavy ion radiotherapy. Radiat. Environ. Biophys. 34:1995;45-48
19. Tsujii H. Oral presentation. In: 8th Heavy Charged Particle Beam Meeting and Second Enlight Meeting. Austria: Baden; 26-28 September 2002.
20. Brahme A, Lewenshon R, Ringborg U, et al. Design of a centre for biologically optimised light ion therapy in Stockholm. Internal Report MSF 2001-01, TERA 01/2 GEN 30.
21. Saunders W., Char D., Quiver J., et al. Precision, high dose radiotherapy: helium ion treatment of uveal melanoma. Int. J. Radiat. Oncol. Biol. Phys. 11:1985;227-233
22. Castro J.R., Phillips T.L., Prados M., et al. Neon heavy charged particle radiotherapy of glioblastoma of the brain. Int. J. Radiat. Oncol. Biol. Phys. 38:1997;257-261
23. Char D.H., Quivey J.M., Castro J.R., et al. Helium ions vs. 125-I in the management of uveal melanoma a prospective randomised dinamically balanced trial. J. Ophthalmol. 100:1993;1547-1551
24. Fuss M., Loredo L.N., Blacharski P.A., Grove R.I., Slater J.D. Proton radiation therapy for medium and large choroidal melanoma: preservation of the eye and its functionality. Int. J. Radiat. Oncol. Biol. Phys. 49:2000;1053-1059
25. Munzenrider J.E. Proton therapy for uveal melanomas and other eye lesions. Strahlenther. Onkol. 175(Suppl 2):1999;68-73
26. Egger E., Schalenbourg A., Zografos L., et al. Maximizing local tumor control and survival after proton beam radiotherapy of uveal melanoma. Int. J. Radiat. Oncol. Biol. Phys. 51(1):2001;138-147
27. Courdi A., Caujolle J.P., Grange J.D., et al. Results of proton therapy of uveal melanomas treated in Nice. Int. J. Radiat. Oncol. Biol. Phys. 45(1):1999;5-11
28. Castro J.R., Linstadt D.E., Bahary J.-P., et al. Experience in charged particle irradiation of tumors of the skull base: 1977-1992. Int. J. Radiat. Oncol. Biol. Phys. 29(4):1994;647-655
29. Nowakowski V.A., Castro J.R., Peti P.L., et al. Charged particle radiotherapy of paraspinal tumours. Int. J. Radiat. Oncol. Biol. Phys. 22:1992;295-303
30. Haberer T., Jakel O., et al. Radiotherapy for chordomas and low-grade chondrosarcomas of the skull base with carbon Ions. Int. J. Radiat. Oncol. Biol. Phys. 53:2002;36-42
31. Ertner Schulz D., NiKoghosyan A., Thilman C., et al. Results of carbon ion radiotherapy in 152 patients. Int. J. Radiat. Oncol. Biol. Phys. 58:2004;631-640
32. Fagundes M.A., Hug E.B., Liebsch N.J., Daly W., Efird J., Munzenrider J.E. Radiation therapy for chordomas of the base of the skull and cervical spine: patterns of failure and outcome after relapse. Int. J. Radiat. Oncol. Biol. Phys. 33:1995;579-584
33. Hug E.B., Fitzek M.M., Liebsch N.J., Munzenrider J.E. Locally challenging osteo-and chondrogenic tumours of the axial skeleton: results of a combined proton and photon radiation therapy using three-dimensional treatment planning. Int. J. Radiat. Oncol. Biol. Phys. 31:1995;467-476
34. Benk V., Munzenrider J.E., Liebsch N.J., et al. Base of skull and cervical spine chordomas in children treated by high-dose irradiation. Int. J. Radiat. Oncol. Biol. Phys. 31:1995;577-580
35. Schoenthaler R., Castro J.R., Petti P.L., Baken-Broen K., Phillips T.L. Charged particle irradiation of sacral chordomas. Int. J. Radiat. Oncol. Biol. Phys. 26:1993;291-298
36. Habrand J.L., Schlienger P., Schwartz L., et al. Clinical applications of proton therapy. Experiences and ongoing studies. Radiat. Environ. Biophys. 34:1995;41-44
37. Laramore G.E., Krall J.M., Thomas F.J., et al. Fast neutron radiotherapy for locally advanced prostate cancer. Final report of Radiation Therapy Oncology Group randomized clinical trial. Am J. Clin. Oncol. 16(2):1993;164-167
38. Russell K.J., Caplan R.J., Laramore G.E., et al. Photon versus fast neutron external beam radiotherapy in the treatment of locally advanced prostate cancer: results of a randomized prospective trial. Int. J. Radiat. Oncol. Biol. Phys. 28(1):1994;47-54
39. Shipley W.U., Verhay L.J., Munzenrider J.E., et al. Advanced prostate cancer: the results of a randomised comparative trial of high dose irradiation boosting with conformal protons compared with conventional dose irradiation using photons alone. Int. J. Radiat. Oncol. Biol. Phys. 32:1995;2-12
40. Yonemoto L.T., Slater J.D., Rossi C.J., et al. Combined proton and photon conformal radiation therapy for locally advanced carcinoma of the prostate: preliminary results of a phase I/II study. Int. J. Radiat. Oncol. Biol. Phys. 37:1997;21-29
41. Rossi C.L., Slater J.D., Reyes-Molyneux N., et al. Particle beam radiation therapy in prostate cancer: is there an advantage? Semin. Radiat. Oncol. 8:1998;115-123
42. Linstadt D.E., Castro J.R., Phillips T.L. Neon ion radiotherapy: results of a phase I/II clinical trial. Int. J. Radiat. Oncol. Biol. Phys. 20:1991;761-769
43. Laramore G.E., Krall J.M., Griffin T.W., et al. Neutron versus photon irradiation for unresectable salivary gland tumours: final report of an RTOG-MRC randomized clinical trial. Int. J. Radiat. Oncol. Biol. Phys. 27:1993;235-240
44. Schultz-Ertner D., Nikoghosyan A., Jaekel O., et al. Feasibility and toxicity of combined photon and carbon ion radiotherapy for locally advanced adenoid cystic carcinoma. Int. J. Radiat. Oncol. Biol. 56:2003;391-398
45. Kamada T., Tsujii H., Yanagi T., et al. Efficacy and safety of carbon ion radiotherapy in bone and soft tissue sarcomas. J. Clin. Oncol. 20:2002;4466-4471
46. Miyamoto T., Yamamoto N., Nishimura H., et al. Carbon ion radiotherapy for stage I non-small cell lung cancer. Radiother. Oncol. 66:2003;127-140
47. Kadono K., Homma T., Kamahara K., et al. Effect of heavy-ion radiotherapy on pulmonary function in stage I non-small cell lung cancer patients. Chest. 122:2002;1925-1932
48. Nishimura H., Miyamoto T., Yamoto N., Koto M., Sugimura K., Tsujii H. Radiographic pulmonary and pleural changes after carbon ion irradiation. Int. J. Radiat. Oncol. Biol. Phys. 55:2003;861-866
49. Kato H., Tsujii H., Ohto M. Short-course radiotherapy with carbon ions for hepatocellular carcinoma. Proceedings of the Second ICTR. Switzerland: Lugano. 16-19 March 2003. Int. J. Radiat. Oncol. Biol. Phys. 55:2003;532
50. Tsujii H. Clinical trials of carbon-ion therapy at NIRS. In: Kraft G, Langbein K, editors. Sixth Workshop on Heavy-Charged Particles in Biology and Medicine. Baveno; 1997.
51. Steinberg G.K., Fabrikant J.I., Marks M.P., et al. Stereotactic heavy charged particle Bragg peak radiation for intracranial arteriovenous malformations. N. Engl. J. Med. 323:1990;96-101
52. Fabrikant J.I., Levy R.P., Steinberg G.K., et al. Charged-particle radiosurgery for intracranial vascular malformations. Neurosurg. Clin. N. Am. 3(1):1992;99-139
53. Kjellberg R.N., Hanamura T., Davis K.R., Lyons S.L., Adams R.D. Bragg-peak proton-beam therapy for arteriovenous malformation of the brain. N. Engl. J. Med. 309:1983;269-274
54. Gademann G. Socio-economics aspects. In: Amaldi U, Larsson B, editors. Hadrontherapy in Oncology. Proceedings of the First International Symposium on Hadrontherapy. Italy: Como; 18-21 October 1993. Elsevier, Excerpta Medica; 1994. p. 53.
55. Orecchia R., Krengli M. Number of potential patients to be treated with proton therapy in Italy. Tumori. 84:1998;205-209